510(k) Report

510(k) · Cleared

Cleared

FullFocus

K201005510(k) TraditionalCleared Jul 15, 202090-day reviewClass II21 CFR 864.3700

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Paige.Ai, Inc. · QKQ Digital Pathology Image Viewing And Management Software

Cleared on Jul 15, 2020 as substantially equivalent to DEN160056 (Philips Medical Systems Nederland B.V., 2017) after a 90-day review. Its family tree reaches back 1 generation to 2017.

Decided
Jul 15, 2020
Review
90 days
Class
Class II
Product code
QKQ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to DEN160056 (2017). No later device cites it as a predicate yet.

DEN160056 · Philips IntelliSite Pathology Solution · Philips Medical Systems Nederland B.V. · 20172016201820202022
  1. Root · 1 generation backDEN160056 Philips IntelliSite Pathology SolutionPhilips Medical Systems Nederland B.V. · 2017
  2. This deviceK201005 FullFocusPaige.Ai, Inc. · 2020
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1DEN160056Philips IntelliSite Pathology SolutionPhilips Medical Systems Nederland B.V.2017—
0 (this device)K201005FullFocusPaige.Ai, Inc.2020—
FIG. 1 — Lineage of K201005, 2017–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QKQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QKQ device

  1. #1 K261380 Concentriq AP-Dxscore 12.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*DEN160056Philips IntelliSite Pathology Solution
Summary page 4
…The FullFocus Viewer Predicate Device Proprietary/Trade Name: Philips IntelliSite Pathology Solution (PIPS) Submission Number: DEN160056 Device Description FullFocus is a web-based software-only device for viewing and manipulating digital pathology images of glas…
Philips Medical Systems Nederland B.V.2017—

Also cleared against DEN160056: 8 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 8 other devices also cite its predicate DEN160056.

How does its category compare?

All QKQ devices

QKQ Digital Pathology Image Viewing And Management Software: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · QKQ

7in 2025

2020: 22022: 22024: 22025: 72026 (partial year): 1
2007high 7 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QKQ

226in 2025

2025: 226 days median
2007high 226 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QKQ

No recall names QKQ since 2007.

Adverse event reports per year · QKQ

No MAUDE report names QKQ since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20202—00
20210—00
20222—00
20230—00
20242—00
2025722600
20261—0—

What is it indicated for?

FullFocus™ is a software only device intended for viewing and management of digital images of scanned surgical pathology slides prepared from formalin-fixed paraffin embedded (FFPE) tissue. It is an aid to the pathologist to review, interpret, and manage digital images of pathology slides for primary diagnosis. FullFocus is not intended for use with frozen sections, cytology, or non-FFPE hematopathology specimens. It is the responsibility of a qualified…

Read the full statement (118 words)

FullFocus™ is a software only device intended for viewing and management of digital images of scanned surgical pathology slides prepared from formalin-fixed paraffin embedded (FFPE) tissue. It is an aid to the pathologist to review, interpret, and manage digital images of pathology slides for primary diagnosis. FullFocus is not intended for use with frozen sections, cytology, or non-FFPE hematopathology specimens.

It is the responsibility of a qualified pathologist to employ appropriate procedures and safeguards to assure the quality of the images obtained and, where necessary, use conventional light microscopy review when making a diagnostic decision. FullFocus is intended for use with Philips Ultra Fast Scanner and monitor displays validated with verified test methods to meet required performance characteristics.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K201005: FullFocus.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K201005

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026